EXO-OC Study Outcome Investor Webinar Presentation
Filed with ASX · · 27 pages · English
In the deck
Earlier from Inoviq
- Quarterly Activities Report and Appendix 4C - June 2026
- EXO-OC algorithm and clinical study update
- Positive CAR-exosome data in ovarian cancer
- Quarterly Activities Report and Appendix 4C - March 2026
- Appendix 4D and FY26 Half Year Financial Report
Later from Inoviq
- EXO-OC Technical Review and Commercialisation Pathway
- INOVIQ Announces Leadership Change
- Quarterly Activities Report and Appendix 4C - September 2026
- IIQ signs EXO-OC validation agreement with Sonic Healthcare
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq